NexImmune, Inc. (NEXI)
NASDAQ: NEXI · IEX Real-Time Price · USD
5.60
+0.09 (1.63%)
Mar 28, 2024, 3:59 PM EDT - Market closed
NexImmune Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NexImmune.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for NexImmune.
Recommendation Trends
Rating | Jun '22 | Jul '22 | Aug '22 | Sep '22 | Oct '22 | Nov '22 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 16, 2022 |
Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2022 |
Barclays | Barclays | Buy Maintains $175 → $50 | Buy | Maintains | $175 → $50 | +792.86% | Aug 16, 2022 |
Raymond James | Raymond James | Buy Maintains $300 → $75 | Buy | Maintains | $300 → $75 | +1,239.29% | Aug 16, 2022 |
BTIG | BTIG | Strong Buy Initiates $125 | Strong Buy | Initiates | $125 | +2,132.14% | Jun 1, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.65
from -65.00
EPS Next Year
-0.15
from -0.65
Revenue Forecast
Revenue | 2023 | 2024 | 2025 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2023 | 2024 | 2025 |
---|---|---|---|
High | -0.67 | -0.16 | -0.09 |
Avg | -0.65 | -0.15 | -0.09 |
Low | -0.63 | -0.15 | -0.09 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.